[{"id":2837,"name":"Invitation to the presentation of Elekta’s fiscal year 2024/25","url":"https://ir.elekta.com/investors/press-releases/2025/invitation-to-the-presentation-of-elektas-fiscal-year-202425/","date":"2025-05-13T05:30:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2024/25 at 10:00 a.m. CET on May 28. The year-end report will be published at 7:30 a.m. CEST on the same day.</strong></p>","regulatory":false},{"id":2835,"name":"Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer","url":"https://ir.elekta.com/investors/press-releases/2025/clinical-trial-shows-more-precise-radiotherapy-using-elekta-unity-mr-linac-preserves-sexual-function-in-men-with-prostate-cancer/","date":"2025-05-03T13:45:00.000Z","intro":"<p><em><strong>ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection</strong></em></p>","regulatory":false},{"id":2828,"name":"Invitation to Elekta's Investor Update event on June 10, 2025","url":"https://ir.elekta.com/investors/press-releases/2025/invitation-to-elektas-investor-update-event-on-june-10-2025/","date":"2025-04-16T05:30:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) is pleased to invite investors, analysts, and other interested stakeholders to attend our Investor Update event on June 10, 2025, at 13:00 CEST. This seminar will feature presentations from Jonas Bolander, Elekta’s Acting President and CEO; Tobias Hägglöv, CFO, along with other leaders of Elekta.</strong></p>","regulatory":false},{"id":2826,"name":"Elekta and Azra AI announce partnership to enhance cancer registry operations with AI-powered automation","url":"https://ir.elekta.com/investors/press-releases/2025/elekta-and-azra-ai-announce-partnership-to-enhance-cancer-registry-operations-with-ai-powered-automation/","date":"2025-04-03T05:30:00.000Z","intro":"<p><em><strong>Collaboration between Azra AI and Elekta will boost cancer registry workflow efficiency, reduce manual data entry, and set the stage for future advancements</strong></em></p>","regulatory":false},{"id":2823,"name":"Gustaf Salford to leave position as President and CEO of Elekta as of March 6","url":"https://ir.elekta.com/investors/press-releases/2025/gustaf-salford-to-leave-position-as-president-and-ceo-of-elekta-as-of-march-6/","date":"2025-02-26T17:00:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) announced today that Gustaf Salford, President and CEO, and the Board of Directors, have decided that Gustaf will leave Elekta as of March 6. Jonas Bolander, Executive Vice President, General Counsel &amp; Head of Group Functions, will assume the CEO position until a new CEO is in office.</strong></p>","regulatory":true}]